EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers

Yixin Jin, Claire Dunn, Irene Persiconi iD, Adam Sike, Gjertrud Skorstad, Carole Beck iD, Jon Amund Kyte iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25010586 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yixin Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norwegian Cancer Society, Novo Seeds, South-Eastern Norway Regional Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have developed a chimeric antigen receptor (CAR) against the six-transmembrane epithelial antigen of prostate-1 (STEAP1), which is expressed in prostate cancer, Ewing sarcoma, and other malignancies. In the present study, we investigated the effect of substituting costimulatory domains and spacers in this STEAP1 CAR. We cloned four CAR constructs with either CD28 or 4-1BB costimulatory domains, combined with a CD8a-spacer (sp) or a mutated IgG-spacer. The CAR T-cells were evaluated in short- and long-term in vitro T-cell assays, measuring cytokine production, tumor cell killing, and CAR T-cell expansion and phenotype. A xenograft mouse model of prostate cancer was used for in vivo comparison. All four CAR constructs conferred CD4+ and CD8+ T cells with STEAP1-specific functionality. A CD8sp_41BBz construct and an IgGsp_CD28z construct were selected for a more extensive comparison. The IgGsp_CD28z CAR gave stronger cytokine responses and killing in overnight caspase assays. However, the 41BB-containing CAR mediated more killing (IncuCyte) over one week. Upon six repeated stimulations, the CD8sp_41BBz CAR T cells showed superior expansion and lower expression of exhaustion markers (PD1, LAG3, TIGIT, TIM3, and CD25). In vivo, both the CAR T variants had comparable anti-tumor activity, but persisting CAR T-cells in tumors were only detected for the 41BBz variant. In conclusion, the CD8sp_41BBz STEAP1 CAR T cells had superior expansion and survival in vitro and in vivo, compared to the IgGsp_CD28z counterpart, and a less exhausted phenotype upon repeated antigen exposure. Such persistence may be important for clinical efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsReceptors, Chimeric AntigenAnimalsHumansMaleMiceAntigens, NeoplasmCD8-Positive T-LymphocytesCytokinesDisease Models, AnimalOxidoreductasesProstate

Stichwörter der Autor:innen

4-1BBCAR spacerCD28STEAP1T cell phenotypecell therapychimeric antigen receptorcostimulatory domainprostate cancerxenograft mouse model

Substanzen

Antigens, NeoplasmCytokinesOxidoreductasesReceptors, Chimeric AntigenSTEAP1 protein, human

Autor:innen und Institutionen

  • Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
  • Department of Clinical Cancer Research, Oslo University Hospital, 0424 Oslo, Norway.
  • Faculty of Health Sciences, Oslo Metropolitan University, 0130 Oslo, Norway.

ORCID-Profile: Irene Persiconi, Carole Beck, Jon Amund Kyte

Förderung

  • Norwegian Cancer Society
  • Novo Seeds
  • South-Eastern Norway Regional Health Authority
  • Oslo University Hospital

Zitieren

APA

Jin, Y., Dunn, C., Persiconi, I., Sike, A., Skorstad, G., Beck, C., & Kyte, J. A. (2024). Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010586

Vancouver

Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25010586

BibTeX
@article{Jin2024,
  author = {Jin, Yixin and Dunn, Claire and Persiconi, Irene and Sike, Adam and Skorstad, Gjertrud and Beck, Carole and Kyte, Jon Amund},
  title = {Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25010586}
}
Kostenlos starten →